A detailed history of Dg Capital Management, LLC transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Dg Capital Management, LLC holds 1,522,204 shares of FENC stock, worth $8.1 Million. This represents 4.41% of its overall portfolio holdings.

Number of Shares
1,522,204
Previous 1,634,811 6.89%
Holding current value
$8.1 Million
Previous $9.99 Million 23.8%
% of portfolio
4.41%
Previous 3.85%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$4.85 - $6.73 $546,143 - $757,845
-112,607 Reduced 6.89%
1,522,204 $7.61 Million
Q2 2024

Aug 14, 2024

BUY
$6.02 - $10.99 $741,350 - $1.35 Million
123,148 Added 8.15%
1,634,811 $9.99 Million
Q1 2024

May 14, 2024

BUY
$8.82 - $11.12 $3.85 Million - $4.85 Million
436,029 Added 40.54%
1,511,663 $16.8 Million
Q4 2023

Feb 12, 2024

SELL
$6.48 - $11.61 $437,173 - $783,268
-67,465 Reduced 5.9%
1,075,634 $12.1 Million
Q3 2023

Nov 14, 2023

BUY
$7.15 - $8.94 $489,381 - $611,898
68,445 Added 6.37%
1,143,099 $8.58 Million
Q2 2023

Aug 11, 2023

SELL
$7.27 - $9.82 $1.28 Million - $1.72 Million
-175,442 Reduced 14.03%
1,074,654 $9.49 Million
Q1 2023

May 11, 2023

BUY
$7.38 - $10.35 $1.68 Million - $2.36 Million
228,144 Added 22.32%
1,250,096 $10.4 Million
Q4 2022

Feb 13, 2023

BUY
$7.63 - $10.22 $128,573 - $172,217
16,851 Added 1.68%
1,021,952 $9.81 Million
Q3 2022

Nov 14, 2022

SELL
$5.71 - $8.54 $1.17 Million - $1.76 Million
-205,537 Reduced 16.98%
1,005,101 $8.14 Million
Q1 2022

May 11, 2022

BUY
$4.29 - $6.08 $219,858 - $311,593
51,249 Added 4.42%
1,210,638 $6.78 Million
Q4 2021

Feb 14, 2022

BUY
$3.89 - $10.01 $2.1 Million - $5.41 Million
540,938 Added 87.47%
1,159,389 $5.1 Million
Q3 2021

Nov 12, 2021

BUY
$6.51 - $9.62 $193,203 - $285,502
29,678 Added 5.04%
618,451 $5.83 Million
Q2 2021

Aug 12, 2021

BUY
$5.96 - $7.85 $3.51 Million - $4.62 Million
588,773 New
588,773 $4.29 Million

Others Institutions Holding FENC

About FENNEC PHARMACEUTICALS INC.


  • Ticker FENC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,067,300
  • Market Cap $139M
  • Description
  • Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...
More about FENC
Track This Portfolio

Track Dg Capital Management, LLC Portfolio

Follow Dg Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dg Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dg Capital Management, LLC with notifications on news.